- 专利标题： Compositions of Glycopyrronium Salt for Inhalation
-
申请号： US14960472申请日： 2015-12-07
-
公开(公告)号： US20160081934A1公开(公告)日： 2016-03-24
- 发明人: Barbara Haeberlin , Frank Stowasser , Wolfgang Wirth , Anton Baumberger , Stephen Abel , Sebastian Kaerger , Thomas Kieckbusch
- 申请人： Barbara Haeberlin , Frank Stowasser , Wolfgang Wirth , Anton Baumberger , Stephen Abel , Sebastian Kaerger , Thomas Kieckbusch
- 申请人地址： CH Basel
- 专利权人： Novartis AG
- 当前专利权人： Novartis AG
- 当前专利权人地址： CH Basel
- 优先权： GB0613161.9 20060630
- 主分类号： A61K9/16
- IPC分类号： A61K9/16 ; A61K31/40 ; A61K45/06 ; A61K9/00
摘要：
A process for preparing dry powder formulations of a glycopyrronium salt for inhalation that have good stability. The process involves (a) micronising a glycopyrronium salt together with an anti-adherent agent, and (b) admixing carrier particles to form the dry powder formulation.
公开/授权文献
- US10314784B2 Compositions of glycopyrronium salt for inhalation 公开/授权日：2019-06-11
信息查询
